- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.42%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option and its peers as on 21 August, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | 16.05% | -0.42% | -0.41% | 1.37% | 6.77% | 11.28% | 19.83% | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -4.52% | -0.31% | -1.01% | 0.61% | 3.5% | -6.77% | 8.04% | 14.28% | 16.92% | 14.11% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.66% | 0.07% | -0.07% | 0.97% | 5.68% | 1.7% | 11.14% | 10.16% | 14.05% | 12.13% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 23.27% | -0.4% | -0.88% | 1.43% | 9.85% | 19.12% | 24.15% | 19.25% | 26.46% | 15.04% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 2.72% | -0.03% | -1.43% | -1.99% | 0.11% | 4.99% | 15.77% | 18.42% | 20.37% | 15.3% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 6.52% | -0.2% | -0.21% | 0.6% | 0.22% | 12.28% | 17.88% | 12.65% | 20.63% | 15.66% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -6.9% | 35.22% | 44.46% | -9.08% |
Discrete returns (monthly)
| Month | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 2.29% | -1.03% | -2.44% | -6.81% | 6.98% | -4.59% | 7.71% | 3.1% | 5.95% | 4.02% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 5.14% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 97.89% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 2.11% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 13.26% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.97% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.05% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.05% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.84% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.43% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.41% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 4.21% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.84% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.39% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 3.04% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.03% |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 2.98% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.92% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.82% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.79% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.90% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 1.52% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.50% |
| Aster DM Quality Care Limited | ASTERDM (INE914M01019) | Healthcare Services | 1.35% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.32% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.27% |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 1.23% |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.21% |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 1.15% |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.10% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.09% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.05% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.95% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.93% |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.92% |
| MedPlus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 0.88% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.72% |
| Venus Pipes And Tubes Limited | VENUSPIPES (INE0JA001018) | Industrial Products | 0.69% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.61% |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.54% |
| Bharat Dynamics Limited | BDL (INE171Z01026) | Aerospace & Defense | 0.47% |
| Yes Bank Limited | YESBANK (INE528G01035) | Banks | 0.46% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 July, 2026
NAV history
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 21 August, 2026 | 19.7405 | -0.42% |
| 20 August, 2026 | 19.8240 | 0.31% |
| 19 August, 2026 | 19.7621 | -0.33% |
| 18 August, 2026 | 19.8280 | 0.39% |
| 17 August, 2026 | 19.7511 | -0.35% |
| 14 August, 2026 | 19.8213 | -0.31% |
| 13 August, 2026 | 19.8837 | -0.23% |
| 12 August, 2026 | 19.9290 | -0.81% |
| 11 August, 2026 | 20.0910 | 0.46% |
| 10 August, 2026 | 19.9985 | 0.09% |
| 7 August, 2026 | 19.9801 | 0.4% |
| 6 August, 2026 | 19.9011 | 0.4% |
| 5 August, 2026 | 19.8226 | 0.15% |
| 4 August, 2026 | 19.7923 | -0.11% |
| 3 August, 2026 | 19.8134 | 0.5% |
| 31 July, 2026 | 19.7147 | 0.24% |
| 30 July, 2026 | 19.6672 | -0.14% |
| 29 July, 2026 | 19.6945 | 1.23% |
| 28 July, 2026 | 19.4545 | 0.06% |
| 27 July, 2026 | 19.4438 | 1.6% |
| 24 July, 2026 | 19.1367 | -0.23% |
| 23 July, 2026 | 19.1816 | -0.41% |
| 22 July, 2026 | 19.2612 | -1.09% |
| 21 July, 2026 | 19.4738 | 0.32% |
| 20 July, 2026 | 19.4115 | 1.28% |
| 17 July, 2026 | 19.1660 | -1.18% |
| 16 July, 2026 | 19.3939 | 0.01% |
| 15 July, 2026 | 19.3917 | 0.36% |
| 14 July, 2026 | 19.3220 | 0.56% |
| 13 July, 2026 | 19.2137 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 19.7405 as on 21 August, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 16.05% as on 21 August, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 11.28% as on 21 August, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 19.83% as on 21 August, 2026.